Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma. Ursprung S, Priest AN, Zaccagna F, Qian W, et al. PLoS One 2021;16:e0258988.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ursprung S, Priest AN, Zaccagna F, Qian W, et al. Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma. PLoS One 2021;16:e0258988.
PMID: 34699525